@CKD_ce

This account is verified. Learn more

@ckd_ce

Your source for joint-accredited serialized tweetorials in the CKD space! See all tweetorials--and still earn credit from AcademicCME--at ckd-ce.com

ckd-ce.com Joined July 2021

40 Following 2.6K Followers 5.5K Posts

Latest posts 5

@CKD_ce @ckd_ce Feb 18

1) Welcome to a new #accredited #tweetorial from @ckd_ce & @cardiomet_ce, addressing new & exciting data released in 2025 on the first major advancement in #hypertension therapy in 20 years! We're talking about #aldosterone synthase inhibitors #ASI for difficult-to-control #HTN.

@CKD_ce @ckd_ce Nov 4, 2025

1) Welcome to a new #accredited #tweetorial from @ckd_ce and @cardiomet_ce, addressing Phase 3 data from #ESC2025 on the first major advancement in #hypertension therapy in 20 years! We're talking about #aldosterone synthase inhibitors #ASI for difficult-to-control #HTN.

@CKD_ce @ckd_ce Oct 26, 2025

Everyone please check out a great new blogpost from @ISNkidneycare on #FXI/XIa-targeted anticoagulation in pts with #ESKD. Might safer #anticoagulation change outcomes?
🔓kireportscommunity.org/post/bleeding-…

www.kireportscommunity.org Bleeding, Clotting, and Kidney Disease in Atrial Fibrillation: Can Factor XI Inhibitors Change the... Explore how we are uncoupling hemostasis and thrombosis via Factor XI inhibitors and how it is may change anticoagulation for atrial fibrillation in kidney disease

@CKD_ce @ckd_ce Sep 3, 2025

1) Welcome to an update from Madrid 🇪🇸 and #ESCCongress, where your faithful @ckd_ce
correspondents grabbed latest data on #aldosterone synthase inhibitors #ASIs & difficult-to-treat "resistant" #HTN. We SCORED, as new Phase 3 data were presented in a #LBCT.

0:09

@CKD_ce @ckd_ce May 28, 2025

1) A new #accredited #tweetorial!
📌The Importance to Cardiorenal Outcomes of Effective Blood Pressure Control & the Pathophysiologic Role of Aldosterone Dysregulation. Our returning expert faculty is Sophia Ambruso DO @Sophia_Kidney, nephrologist & podcaster @freelyfiltered